Background According to a meta-analysis of randomized clinical trials, paclitaxel-coated
devices (PCDs) for lower limb endovascular revascularization may be associated with …

BACKGROUND The long‐term safety of paclitaxel‐coated devices (PCDs; drug‐coated
balloon or drug‐eluting stent) for peripheral endovascular intervention is uncertain. We used …

Background The results of a recent meta-analysis aroused concern about an increased risk
of death associated with the use of paclitaxel-coated angioplasty balloons and stents in …

A recent meta-analysis addressed increased risk of death following revascularization with
paclitaxel-coated devices in femopopliteal artery. We evaluated differences in all-cause …

Background Meta-analyses of randomised trials of paclitaxel-coated peripheral devices
found an association with worse long-term survival. Aims We aimed to assess long-term …

Objective This observational cohort study examined outcomes after peripheral vascular
intervention (PVI) with paclitaxel coated devices (PCD) and non-PCD, and evaluated …

Abstract Purpose of Review Peripheral artery disease (PAD) is a common, debilitating
disease that impacts 8.5 million Americans and carries a poor prognosis. The most common …

Advances in technology have led to the emergence of endovascular therapy as a primary
treatment option for patients with peripheral artery disease (PAD), with the goal of improving …

Background: Randomized controlled trials have reported excess mortality in patients treated
with paclitaxel-coated devices versus uncoated devices, while observational studies have …

Background Recent evidence raised the concern that paclitaxel-containing therapy was
associated with an increased risk of mortality in patients with peripheral artery diseases …